|
|
Research Management and Support
|
RMS2008
|
$336,082,664
|
$130,850
|
N/A
|
National Cancer Institute
|
|
|
p53 - Regulators and Effectors
|
5P01CA080058-09
|
$1,348,536
|
$67,427
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
|
Cellular Senescence in Aging and Cancer
|
5R01CA085214-10
|
$453,735
|
$453,735
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
|
Training Program in Cancer Biology
|
5T32CA078207-10
|
$443,412
|
$39,907
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
|
Modeling androgen-independent prostate cancer in mutant mice
|
7R01CA115717-02
|
$305,900
|
$76,475
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
$361,526
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Modeling Prostate Tumorigenesis
|
2R01CA094858-06A1
|
$230,554
|
$57,639
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
5R01CA123484-02
|
$291,406
|
$72,852
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY
|
|
|
PHASE I SINGLE AND MULTIPLE-DOSE SAFETY AND PHARMACOKINETIC CLINICAL STUDY OF LYC
|
N01CN085081-008
|
|
$0
|
ABEITA, CATHY
|
University of Illinois at Chicago
|
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$56,979
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
|
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
|
5U54CA091431-08
|
$1,535,549
|
$460,665
|
ADAMS-CAMPBELL, LUCILE
|
HOWARD UNIVERSITY
|
|
|
A Transgenic Model for Prostate Tumor Immunity
|
5R01CA109339-05
|
$281,848
|
$70,462
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-08
|
$1,710,826
|
$192,468
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
|
Prostate Cancer Prevention by Procyanidins in Grape Seed Extract
|
2R01CA091883-06A1
|
$334,640
|
$83,660
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Prostate Cancer Chemoprevention by Inositol Hexaphosphate Efficacy and Mechanism
|
5R01CA116636-03
|
$261,397
|
$261,397
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Role of NCoR in Antiandrogen Resistance in Prostate Cancer
|
1R21CA129265-01A1
|
$207,225
|
$51,806
|
AGOULNIK, IRINA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Targeting Relaxin Signaling in Prostate Cancer
|
5R21CA118362-02
|
$150,000
|
$37,500
|
Agoulnik, Alexander
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
SELECT Pre-Clinical Trial of Prostate Cancer
|
5R01CA114060-03
|
$250,774
|
$62,694
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Phase III Trial of Selenium for Prostate Cancer Prevention
|
5R01CA077789-10
|
$588,097
|
$147,024
|
Ahmann, Frederick
|
UNIVERSITY OF ARIZONA
|
|
|
Studies of Normal and Neoplastic Prostate
|
5U01CA015062-33
|
$215,048
|
$53,762
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
|
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
|
1P20CA138018-01
|
$135,639
|
$8,545
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Training Program in Cancer Biology
|
5T32CA079448-09
|
$491,121
|
$61,390
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Using Markov Decision Processes to Optimize Breast Biopsy Decision Making
|
1R21CA129393-01A1
|
$185,293
|
$92,647
|
Alagoz, Oguzhan
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
SBIR TOPIC 236 PHASE 1 ANTIBODY ARRAY FOR CANCER DETECTION
|
N43CN800021-000
|
$149,995
|
$12,375
|
ALAM, MAKSUDUL
|
INNOSENSE, LLC
|
|
|
ATBC Study
|
Z01 CP010195-03031
|
$759,338
|
$37,967
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Comprehensive MRI, MRS and Molecular Analyses: Pten-based Prostate Cancer Models
|
5R01CA129003-02
|
$291,650
|
$72,913
|
ALBANESE, CHRISTOPHER
|
GEORGETOWN UNIVERSITY
|
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-09
|
$446,225
|
$44,623
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
$356,735
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
$9,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-09
|
$511,052
|
$102,210
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-04S1
|
$83,552
|
$83,552
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Detroit CNP: "Social Network Analysis for CNP Partnerships"
|
3U01CA114583-04S2A1
|
$75,250
|
$75,250
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-04
|
$473,207
|
$473,207
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
CANCER INFORMATION SERVICE
|
N02CO511003-005
|
$630,200
|
$17,331
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Immunotherapeutic Approaches to Cancer Treatment
|
1R41CA130493-01A1
|
$123,614
|
$30,904
|
ALEXANDER, RICHARD
|
VIROGENOMICS, INC.
|
|
|
SURFACE ANTIGENS OF MURINE T LYMPHOMAS
|
5R01CA040041-23
|
$311,649
|
$20,257
|
ALLISON, JAMES
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Deformable registration for image-guided radiotherapy
|
5F32CA124138-02
|
$46,826
|
$11,707
|
Alterovitz, Ron
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-09
|
$288,775
|
$14,439
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Lung cancer molecular markers by sex: intergroup study
|
5R01CA106815-05
|
$559,505
|
$27,975
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Race & Risk Factors for Early/Aggressive Breast Cancer
|
7R01CA100598-05
|
$684,259
|
$342,130
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
General Descriptive Studies
|
Z01 CP010183-00350
|
$156,344
|
$15,634
|
Anderson, William
|
DCEG (NCI)
|
|
|
THE THERAPY OF AML
|
5P01CA055164-16
|
$2,374,635
|
$2,374,635
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
1K99CA131489-01A1
|
$131,088
|
$16,386
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
|
Extension of Radiotherapy Research
|
5P01CA006294-44
|
$1,516,143
|
$37,904
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Mouse Models of Sporadic Colorectal Cancer
|
1K01CA128891-01A1
|
$103,365
|
$25,841
|
Angus-Hill, Melinda
|
UNIVERSITY OF UTAH
|
|
|
EGFR antisense DNA added to cetuximab and radiotherapy for head and neck cancer
|
1R21CA130241-01A1
|
$330,678
|
$82,670
|
ARGIRIS, ATHANASSIOS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Telomere Shortening and Stem Cell Maintenance
|
5K08CA118416-03
|
$140,010
|
$70,005
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Telomeres, Telomerase and Tumor Progression
|
5R01CA111691-04
|
$328,430
|
$82,108
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
|
SPORE in Breast Cancer
|
2P50CA098131-06
|
$2,300,000
|
$184,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
|
Development of Ets2-Inhibitors
|
1R15CA125724-01A2
|
$222,376
|
$27,797
|
ARYA, DEV
|
CLEMSON UNIVERSITY
|
|
Total relevant funding to Aging for this search: $162,224,132
|
